Apellis Pharmaceuticals, Inc. (FRA:1JK)
Germany flag Germany · Delayed Price · Currency is EUR
18.50
-0.04 (-0.21%)
At close: Jan 30, 2026

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
EMPAVELI Revenue
90.67M98.09M
SYFOVRE Revenue
599.54M611.86M
Total Product Revenue
690.21M709.95M
Licensing and Other Revenue
326.18M71.41M
Revenue (Total)
1.02B781.37M
Updated Sep 30, 2025. Data Source: Fiscal.ai.